Dr. Reddy's Laboratories Limited (NSE:DRREDDY)
1,174.70
-5.30 (-0.45%)
Aug 21, 2026, 3:15 PM IST
Dr. Reddy's Laboratories Market Cap
Dr. Reddy's Laboratories has a market cap or net worth of 978.76 billion as of August 21, 2026. Its market cap has decreased by -5.60% in one year.
Market Cap
978.76B
Enterprise Value
972.59B
Revenue
331.19B
Ranking
n/a
PE Ratio
29.56
Stock Price
1,174.70
ChartMarket Cap Chart
Since May 31, 1999, Dr. Reddy's Laboratories's market cap has increased from 21.00B to 978.76B, an increase of 4,559.77%. That is a compound annual growth rate of 15.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 978.76B | -7.51% |
| Dec 31, 2025 | 1.06T | -8.50% |
| Dec 31, 2024 | 1.16T | 19.80% |
| Dec 29, 2023 | 965.41B | 37.28% |
| Dec 30, 2022 | 703.23B | -13.66% |
| Dec 31, 2021 | 814.50B | -5.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 2.28T |
| Cipla | 1.16T |
| Zydus Lifesciences | 1.12T |
| Mankind Pharma | 984.58B |
| Laurus Labs | 973.64B |
| Aurobindo Pharma | 932.86B |
| Glenmark Pharmaceuticals | 654.11B |
| Alkem Laboratories | 645.65B |